Oxurion Announces Two Upcoming Presentations at The Macula Society 45th Annual Meeting
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 26 - Tom Graney News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tom Graney Today - Breaking & Trending Today
Oxurion Announces Two Upcoming Presentations at The Macula
Leuven, BELGIUM, Boston, MA, US – JUNE 3, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of...
Source: globenewswire.com
Investegate |Oxurion NV Announcements | Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Investegate announcements from Oxurion NV, Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Source: investegate.co.uk
Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA
Negma Group has converted 200 convertible bonds in Oxurion resulting in a EUR 500,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion to focus
Source: finanznachrichten.de
Oxurion NV: Oxurion Announces Results of the Extraordinary Shareholders' Meeting held on 24 May 2022
Leuven, Belgium, Boston, MA, US - May 25, 2022 - 07.00 PM CET - Oxurion NV(Euronext Brussels: OXUR) (the "Company" or "Oxurion"), a biopharmaceutical company developing next generation
Source: finanznachrichten.de